Data as of 3:59pm ET
| -0.04 / -0.67%|
The 2 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 8.77, with a high estimate of 9.17 and a low estimate of 8.38. The median estimate represents a +47.71% increase from the last price of 5.94.
The current consensus among 2 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.